Los Angeles, California–(Newsfile Corp. – July 1, 2022) – CIO Review announces Innovation Vista as Most Promising Emerging Digital Transformation company of 2022. Innovation Vista has built a vast network of former C-level IT executives, who are selected for each client based on their technical expertise and industry experience. Innovation Vista has filled a market void by offering IT Consulting services to small and medium-sized businesses. The company also offers Innovative Consulting, which helps companies design new products, services, supply chains, and/or entire business models by partnering with third-party experts. Consultants with innovative ideas work together with their clients’ staff and management to develop solutions.
Innovation Vista -Award Winning Image
To view an enhanced version of this graphic, please visit:
https://healthtechnologynet.com/wp-content/uploads/2022/07/129792_0f7d066084f2ba92_001full.jpg
Innovation Vista and its CEO Jeff Roberts take their leading-edge network of over 300 CIO’s and leverage their experience for small to mid-market businesses that don’t have access to the same innovations available to enterprise companies. The CIO Review placed Innovation Vista of the cover of their most recent Digital Transformation edition. Innovation Vista was ranked based on unique characteristics vs. other IT strategy consultancies.
Innovation Vista -Logo Image
To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/8397/129792_0f7d066084f2ba92_002full.jpg
Innovation Vista’s C-level consultants help these companies optimize their IT and data while minimizing their spending by assessing their systems and determining the best approach for each technology.
Part of CIO Review pointed out Innovation Vista’s competitive edge by in leveraging the latest technologies such as artificial intelligence, augmented reality, virtual reality, robotic process automation, and robotics.
For more information, please visit:
Website- https://innovationvista.com/
Media Contact- Jeff Roberts
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/129792
New molecule demonstrates efficacy in a challenging SCI modelExpanding pipeline into new indications of ischemic…
The Company will ship 160 doses of MDMA and psilocybin to Australian psychiatrists for the…
Remote monitoring reduces office visit and treatment burden in some patientsManassas, Virginia--(Newsfile Corp. - June…
Discussions to focus on constructively bridging the tension of usability, privacy, security, and identity WASHINGTON,…
ZURICH, SWITZERLAND / ACCESSWIRE / June 25, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or…
The Executives Will Support the Company with Deep Expertise Across Entertainment, Development and Distribution JUPITER,…
